(Q34285830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

meta-analysis

0 references

title

Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nurcan Üçeyler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

Association of the Scientific Medical Societies in Germany

6 February 2020

11

object named as

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

C Sommer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R Alten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

F Petzke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Späth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

T Tölle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Winkelmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E Winter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

K J Bär

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

German

0 references

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

297-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00482-012-1172-2

6 February 2020

exact match

0 references

cites work

Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

High prevalence of growth hormone deficiency in severe fibromyalgia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Zopiclone in the treatment of sleep abnormalities in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

The effect of guided imagery and amitriptyline on daily fibromyalgia pain: a prospective, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Differential efficacy of a cognitive-behavioral intervention versus pharmacological treatment in the management of fibromyalgic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A comparative study of fibromyalgia treatment: ultrasonography and physiotherapy versus sertraline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effect of amitriptyline vs. physiotherapy in management of fibromyalgia syndrome: What predicts a clinical benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Chlormezanone in primary fibromyalgia syndrome: a double blind placebo controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Nabilone for the treatment of pain in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Pharmacological treatment of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Fibromyalgia symptoms relieved by flupirtine: an open-label case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized controlled trial of acupuncture added to usual treatment for fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Tramadol dependence: a survey of spontaneously reported cases in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effect of intravenous lidocaine on manifestations of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

The abuse potential of the synthetic cannabinoid nabilone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-012-1172-2

Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials

21 January 2018

1 reference

12 December 2020

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia

1 reference

12 December 2020

A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.

1 reference

12 December 2020

Fibromyalgia--are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs.

1 reference

12 December 2020

A randomized controlled trial of citalopram in the treatment of fibromyalgia

1 reference

12 December 2020

Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group

1 reference

12 December 2020

The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study

1 reference

12 December 2020

A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.

1 reference

12 December 2020

Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

1 reference

12 December 2020

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study

1 reference

12 December 2020

Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases

1 reference

12 December 2020

Combination of acupuncture, cupping and medicine for treatment of fibromyalgia syndrome: a multi-central randomized controlled trial

1 reference

12 December 2020

Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study

1 reference

12 December 2020

Effects of Stanger bath therapy on fibromyalgia

1 reference

12 December 2020

Adjuvant use of melatonin for treatment of fibromyalgia

1 reference

12 December 2020

Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials

1 reference

12 December 2020

A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis.

1 reference

12 December 2020

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial

1 reference

12 December 2020

Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

1 reference

12 December 2020

Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-alpha

1 reference

12 December 2020

The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia

1 reference

12 December 2020

The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study.

1 reference

12 December 2020

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

12 December 2020

A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures.

1 reference

12 December 2020

Percutaneous fentanyl in fibromyalgia

1 reference

12 December 2020

Vegetarian diet in the treatment of fibromyalgia.

1 reference

12 December 2020

[Flupirtine in chronic myofacial pain conditions]

1 reference

12 December 2020

[Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia]

1 reference

12 December 2020

Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline

1 reference

12 December 2020

Efficacy of tramadol in treatment of pain in fibromyalgia.

1 reference

12 December 2020

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

12 December 2020

Efficacy of milnacipran in patients with fibromyalgia.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

1 reference

12 December 2020

10.1007/S00482-012-1172-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760463%20AND%20SRC:MED&resulttype=core&format=json